Suchergebnisse - "Wagenaar, M"

PubPharm (112)

1

Towards criteria and symptoms of constipation in people with severe or profound intellectual and multiple disabilities : A Delphi study

enthalten in: Heliyon | 2023

von Waninge, A. | Van der Putten, A. | Wagenaar, M. | +1

2

Safety and tolerability of stereotactic radiotherapy combined with durvalumab with or without tremelimumab in advanced non-small cell lung cancer, the phase I SICI trial

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2023

von Kievit, H. | Muntinghe-Wagenaar, M. | Hijmering-Kappelle, L. | +9

3

Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients : Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC)

enthalten in: Frontiers in oncology | 2023

von Meertens, M. | Muntinghe-Wagenaar, M. | Sikkema, B. | +19

4

Intermediate-high risk pulmonary embolism : identification and treatment

enthalten in: Nederlands tijdschrift voor geneeskunde | 2022

von Jager, N. | Eijsvogel, M. | Wagenaar, M. | +2

5

Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis : the PREDMETH study

enthalten in: BMC pulmonary medicine | 2020

von Kahlmann, V. | Janssen Bonás, M. | Moor, C. | +24

6

Correction to : Adaptation and validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for the Netherlands

enthalten in: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation | 2018

von Wapenaar, M. | Twiss, J. | Wagenaar, M. | +6

ErratumFor: Neth Heart J. 2016 Jun;24(6):417-424. - PMID 27197970

7

Correction to: Adaptation and validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for the Netherlands

enthalten in: Netherlands heart journal | 2018

von Wapenaar, M. | Twiss, J. | Wagenaar, M. | +6

8

Correction to: Adaptation and validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for the Netherlands

enthalten in: Netherlands heart journal | 2018

von Wapenaar, M. | Twiss, J. | Wagenaar, M. | +6

9

Serum periostin does not reflect type 2-driven inflammation in COPD

enthalten in: Respiratory research | 2018

von Carpaij, O. | Muntinghe, F. | Wagenaar, M. | +10

10

Serum periostin does not reflect type 2-driven inflammation in COPD

enthalten in: Respiratory research | 2018

von Carpaij, O. | Muntinghe, F. | Wagenaar, M. | +10

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]